You have 9 free searches left this month | for more free features.

Leukemia, Myeloid, Acute

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia Trial in Antalya

Recruiting
  • Acute Myeloid Leukemia
    • Antalya, Turkey
      Antalya Training and Research Hospital
    Jul 29, 2023

    Acute Myeloid Leukemia Trial (Dasatinib)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Sep 20, 2023

    Patients With Acute Myeloid Leukemia

    Recruiting
    • Acute Myeloid Leukemia, Adult
      • Freiburg, CA, Germany
        Medical Center- University of Freiburg
      Aug 4, 2023

      AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

      Not yet recruiting
      • AML
      • +11 more
      • (no location specified)
      Aug 14, 2023

      Frequency and Risk Factors of Acute Myeloid Leukemia

      Not yet recruiting
      • Myeloid Leukemia
      • Bone marrow aspirite for diagnosis
      • (no location specified)
      Mar 15, 2023

      Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

      Recruiting
      • Acute Myeloid Leukemia Refractory
      • Acute Myeloid Leukemia, in Relapse
      • anti Tim-3/CD123 CAR-T cell therapy
      • Xuzhou, Jiangsu, China
        Kailin Xu
      Nov 4, 2023

      A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia

      Not yet recruiting
      • C-KIT Mutation
        • (no location specified)
        Nov 2, 2023

        Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

        Recruiting
        • Acute Myeloid Leukemia
        • Beijing, Beijing, China
          Peking University People's Hospital
        Jun 23, 2023

        Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Mitoxantrone hydrochloride liposome injection
        • +3 more
        • (no location specified)
        May 29, 2023

        Acute Myeloid Leukemia Trial in Taipei

        Enrolling by invitation
        • Acute Myeloid Leukemia
          • Taipei, Taiwan
            National Taiwan University Hospital
          Aug 9, 2023

          Acute Myeloid Leukemia Trial (ABBV-787)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • (no location specified)
          Sep 29, 2023

          Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Oral azacitidine
          • Seoul, Korea, Republic of
            Bristol-Myers Squibb YH
          Oct 3, 2023

          Acute Myeloid Leukemia Trial in Beijing (N-acetyl-L-cysteine)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Beijing, Beijing, China
            Yuan Kong
          Sep 4, 2023

          Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

          Not yet recruiting
          • Acute Myeloid Leukemia, in Relapse
          • Acute Myeloid Leukemia Refractory
          • (no location specified)
          Nov 9, 2023

          Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Mitoxantrone hydrochloride liposome injection
          • +3 more
          • Tianjin, China
            Institute of Hematology & Blood Diseases Hospital
          Jul 1, 2023

          PET Tracer Based FDG Signal for Predicting Prognosis in Acute

          Enrolling by invitation
          • Acute Myeloid Leukemia
          • No intervention
          • Guangzhou, Guangdong, China
            First Affiliated Hospital of Jinan University
          Jun 22, 2023

          Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)

          Not yet recruiting
          • Chemotherapy-Induced Thrombocytopenia
          • Hetrombopag Olamine
          • (no location specified)
          Jul 5, 2023

          Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

          Recruiting
          • Acute Myeloid Leukemia Refractory
          • Lyon, France
            Centre Léon Bérard
          Nov 30, 2023

          Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

          Recruiting
          • Leukemia, Myeloid, Acute
          • Minimal Residual Disease
            • Chapel Hill, North Carolina
              North Carolina Cancer Hospital (NCCH)
            Feb 2, 2023

            Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

            Recruiting
            • Acute Myeloid Leukemia
            • +3 more
            • CD123 targeted CAR-NK cells
            • Taiyuan, Shanxi, China
              Shanxi Bethune Hospital
            Aug 28, 2023

            Leukemia, Myeloid, Acute Trial in Chengdu (Chidamide)

            Recruiting
            • Leukemia, Myeloid, Acute
            • Chengdu, Sichuan, China
              West China Hospital of Sichuan University
            Dec 27, 2022

            Leukemia, Myeloid, Acute Trial in Guangzhou, Hangzhou (BG1805)

            Not yet recruiting
            • Leukemia, Myeloid, Acute
            • BG1805
            • Guangzhou, Guangdong, China
            • +2 more
            Nov 1, 2023

            MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

            Not yet recruiting
            • Myelodysplastic Syndromes
            • +3 more
            • Subcutaneous azacitidine
            • Oral decitabine/cedazuridine
            • Newcastle, New South Wales, Australia
              Calvary Mater Newcastle
            May 29, 2023

            Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)

            Not yet recruiting
            • Acute Myeloid Leukemia
            • High-Risk and Very High-Risk Myelodysplastic Syndromes
            • (no location specified)
            Jul 25, 2023

            iN the Real Practice

            Not yet recruiting
            • Acute Myeloid Leukemia (AML)
            • +2 more
            • Vyxeos liposomal
            • Roma, Italy
              Policlinico Tor Vergata
            Nov 16, 2023